高级检索
邱增辉, 蒋俊男, 姚岚. 城市定制型补充医疗保险参保恶性肿瘤患者经济毒性影响因素分析[J]. 中国公共卫生, 2023, 39(9): 1191-1196. DOI: 10.11847/zgggws1140926
引用本文: 邱增辉, 蒋俊男, 姚岚. 城市定制型补充医疗保险参保恶性肿瘤患者经济毒性影响因素分析[J]. 中国公共卫生, 2023, 39(9): 1191-1196. DOI: 10.11847/zgggws1140926
QIU Zenghui, JIANG Junnan, YAO Lan. Financial toxicity of cancer care and its associates among cancer patients with urban customized supplementary medical insurance in a Chinese city: a telephone survey[J]. Chinese Journal of Public Health, 2023, 39(9): 1191-1196. DOI: 10.11847/zgggws1140926
Citation: QIU Zenghui, JIANG Junnan, YAO Lan. Financial toxicity of cancer care and its associates among cancer patients with urban customized supplementary medical insurance in a Chinese city: a telephone survey[J]. Chinese Journal of Public Health, 2023, 39(9): 1191-1196. DOI: 10.11847/zgggws1140926

城市定制型补充医疗保险参保恶性肿瘤患者经济毒性影响因素分析

Financial toxicity of cancer care and its associates among cancer patients with urban customized supplementary medical insurance in a Chinese city: a telephone survey

  • 摘要:
      目的  了解城市定制型补充医疗保险(定制险)参保恶性肿瘤患者的经济毒性及其影响因素,为优化完善定制险及制定经济毒性干预措施提供政策参考。
      方法  于2021年7 — 8月采用一般情况调查表和经济毒性综合评分量表(COST)对在Z市恶性肿瘤患者数据库中随机抽取的600例在2020年12月之后前往当地公立医院就诊过的定制险参保恶性肿瘤患者进行电话回访调查,应用多元逐步线性回归模型分析定制险参保恶性肿瘤患者经济毒性的影响因素。
      结果  本研究最终纳入的560例定制险参保恶性肿瘤患者的COST量表评分为(17.90 ± 8.01)分,其中轻度经济毒性89例(15.9%)、中度经济毒性307例(54.8%)、重度经济毒性164例(29.3%);多元逐步线性回归分析结果显示,农业户籍、年龄45~59岁、过去1年自费药品支出 ≥ 10000元、过去1年因癌症治疗而借过钱和过去1年因经济困难而放弃治疗的定制险参保恶性肿瘤患者的经济毒性较高;参加了其他商业健康保险、过去1年家庭总收入 ≥ 100000元、过去1年家庭消费性支出 ≥ 100000元和过去1年因癌症住院治疗次数为1 ~ 4次的定制险参保恶性肿瘤患者的经济毒性较低。
      结论  经济毒性在定制险参保恶性肿瘤患者中普遍存在,社会人口学因素和家庭经济因素均会对其经济毒性产生影响,应从多方面对恶性肿瘤患者的经济毒性进行有效干预。

     

    Abstract:
      Objective  To examine the financial toxicity (FT) of cancer care among cancer patients covered by urban customized supplementary medical insurance (customized insurance) and its influencing factors for providing evidence to the optimization of customized insurance and the development of FT-related intervention measures.
      Methods  Using random sampling and a self-designed questionnaire, we conducted telephone interviews among 600 registered cancer patients with customized insurance and ever attending local public hospitals for medication after December 2020 during July – August 2021 in a city. The Comprehensive Scores for Financial Toxicity (COST) scale was adopted to assess FT of cancer treatment. The influencing factors of FT were analyzed with stepwise multivariate linear regression model.
      Results  For the 560 participants finally included in the analysis, the COST score was 17.90 ± 8.01 and the number (proportion) of the participants with the scores indicating mild, moderate, and severe FT were 89 (15.89%), 307 (54.82%), and 164 (29.29%), respectively. The results of regression analysis showed that the participants with following characteristics were more likely to have a lower COST score indicating severe FT: with agricultural residence registration, aged 45 – 59 years, having an out-of-pocket medication expenditure of 10 000 Chinese Yuan (CNY) and more in the past year, ever borrowing money for cancer treatment in the past year, and abandoning treatment due to financial difficulties in the past year; while, the participants with other commercial health insurance in addition to customized insurance, having a total household income of 100 000 CNY and more in the past year, having a total household consumption expenditure of 100 000 CNY and more in the past year, and having been hospitalized 1 – 4 times for cancer treatment in the past year were more likely to have a higher COST score indicating mild FT.
      Conclusion  FT of cancer is common among cancer patients covered by customized insurance in a Chinese city and the prevalence of FT is impacted by sociodemographic factors and family financial factors, suggesting that effective intervention on FT needs to be carried out in various ways.

     

/

返回文章
返回